Catherine Tang

948 total citations
30 papers, 722 citations indexed

About

Catherine Tang is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Catherine Tang has authored 30 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Catherine Tang's work include Cancer Risks and Factors (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Catherine Tang is often cited by papers focused on Cancer Risks and Factors (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Catherine Tang collaborates with scholars based in Australia, United States and New Zealand. Catherine Tang's co-authors include Vicki Chen, Susette C. Mueller, Lisa L. Wei, Marc E. Lippman, Rebecca Slack, Xiaohong Yang, Ruth Lupu, Marina Cardillo, Karen Rosenberg and Lyndsay N. Harris and has published in prestigious journals such as Blood, Water Research and Desalination.

In The Last Decade

Catherine Tang

24 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Tang Australia 9 236 183 158 133 132 30 722
Camille Grandclément France 9 241 1.0× 239 1.3× 221 1.4× 125 0.9× 136 1.0× 17 1.1k
Yuwei Deng China 17 135 0.6× 71 0.4× 129 0.8× 202 1.5× 191 1.4× 62 813
Zhiyan Liang China 15 195 0.8× 98 0.5× 147 0.9× 74 0.6× 243 1.8× 41 776
Rui‐Cheng Ji Japan 17 116 0.5× 816 4.5× 395 2.5× 97 0.7× 102 0.8× 49 1.3k
Zhaoyang Lu China 12 70 0.3× 189 1.0× 127 0.8× 44 0.3× 48 0.4× 33 704
Dafan Chen China 14 93 0.4× 111 0.6× 103 0.7× 61 0.5× 65 0.5× 29 565
Ruijue Wang China 15 150 0.6× 82 0.4× 173 1.1× 163 1.2× 92 0.7× 33 641
Lyu Zhou China 14 136 0.6× 111 0.6× 156 1.0× 248 1.9× 22 0.2× 30 927
Lie Wang China 11 66 0.3× 128 0.7× 183 1.2× 90 0.7× 55 0.4× 55 633
Nitesh Kumar India 14 136 0.6× 275 1.5× 277 1.8× 114 0.9× 21 0.2× 32 1.2k

Countries citing papers authored by Catherine Tang

Since Specialization
Citations

This map shows the geographic impact of Catherine Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Tang more than expected).

Fields of papers citing papers by Catherine Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Tang. The network helps show where Catherine Tang may publish in the future.

Co-authorship network of co-authors of Catherine Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Tang. A scholar is included among the top collaborators of Catherine Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Tang. Catherine Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldsbury, David, Yoon‐Jung Kang, Catherine Tang, et al.. (2025). Sociodemographic and health factors associated with genetic testing in Australia: insights from a cohort-based study of 45,061 participants. European Journal of Human Genetics. 33(6). 819–824.
2.
Tang, Catherine, Mandeep S. Sagoo, Edward Pringle, et al.. (2025). An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators. British Journal of Haematology. 207(1). 123–131.
3.
Froessler, Bernd, Catherine Tang, Kylie King, et al.. (2025). Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement. Internal Medicine Journal. 55(2). 300–307. 1 indexed citations
4.
Shand, Antonia, Joanne Said, Kim Hobbs, et al.. (2025). Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context. Internal Medicine Journal. 55(3). 393–406.
5.
6.
Xie, Hailong, Chao Cui, Congjian Sun, et al.. (2025). A glycopeptide-based pH-responsive hydrogel promotes diabetic wound healing via antimicrobial and remodeling microenvironment. Colloids and Surfaces B Biointerfaces. 251. 114614–114614. 4 indexed citations
7.
Li, Xiaona, et al.. (2025). Mapping the formation of gemcitabine-immunoglobulin nanoparticles and the subsequent activity against pancreatic cancer cells. International Journal of Biological Macromolecules. 304(Pt 1). 140729–140729.
8.
Barraclough, Allison, Catherine Tang, Masa Lasica, et al.. (2024). Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 55(1). 117–129.
9.
Chadwick, Verity, Catherine Tang, Mary Ann Anderson, et al.. (2023). Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility. The Lancet Haematology. 10(6). e458–e467. 6 indexed citations
10.
Tang, Catherine, Verity Chadwick, Kylie D. Mason, et al.. (2022). Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study. Leukemia & lymphoma. 64(2). 319–328. 6 indexed citations
11.
Shen, Yandong, Asha Soosapilla, Catherine Tang, et al.. (2021). COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity. British Journal of Haematology. 197(1). 41–51. 30 indexed citations
12.
Bagnara, Davide, Catherine Tang, Jennifer R. Brown, et al.. (2021). Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course. Frontiers in Oncology. 11. 640731–640731. 8 indexed citations
13.
Anderson, Mary Ann, et al.. (2021). The untold effect of the combined oral contraceptive pill on anticancer drugs. The Lancet Haematology. 9(1). e10–e11. 1 indexed citations
14.
Campbell, Belinda A., Kylie D. Mason, Matthew Greenwood, et al.. (2021). Lymphoma during Pregnancy: A Multicentre Study By the Australasian Lymphoma Alliance. Blood. 138(Supplement 1). 882–882. 3 indexed citations
15.
Tang, Catherine, David J. Rabbolini, Marie‐Christine Morel‐Kopp, et al.. (2019). The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature. Research and Practice in Thrombosis and Haemostasis. 4(1). 106–110. 3 indexed citations
16.
Polliack, Aaron, Irit Avivi, Yair Herishanu, et al.. (2018). Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity. Leukemia Research. 71. 1–5. 12 indexed citations
17.
Tang, Catherine, Julian Lindsay, Anthony J. Gill, & Ian Kerridge. (2017). Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome. Clinical Lymphoma Myeloma & Leukemia. 17(8). 539–541. 4 indexed citations
18.
Koo, Jenn Hian, et al.. (2011). Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient. Journal of Gastroenterology and Hepatology. 27(2). 390–396. 19 indexed citations
19.
Jiang, Daxin, et al.. (2004). Mining Coherent Gene Clusters from Gene-Sample-Time Microarray Data. 1 indexed citations
20.
Lupu, Ruth, Marina Cardillo, Lyndsay N. Harris, et al.. (1996). The significance ofheregulin in breast cancer tumor progression and drug resistance. Breast Cancer Research and Treatment. 38(1). 57–66. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camille Grandclément Breakdown of academic impact, for papers by Yuwei Deng Breakdown of academic impact, for papers by Zhiyan Liang Breakdown of academic impact, for papers by Rui‐Cheng Ji Breakdown of academic impact, for papers by Zhaoyang Lu Breakdown of academic impact, for papers by Dafan Chen Breakdown of academic impact, for papers by Ruijue Wang Breakdown of academic impact, for papers by Lyu Zhou Breakdown of academic impact, for papers by Lie Wang Breakdown of academic impact, for papers by Nitesh Kumar
Rankless by CCL
2026